SCOPUS 정보 검색 플랫폼

Volumn 89, Issue 4, 2002, Pages 425-430

Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac

(8) White, William B a,e Faich, Gerald b Whelton, Andrew c Maurath, Clement f Ridge, Nancy J d Verburg, Kenneth M d Geis, G Steven d Lefkowith, James B d

a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE (United States)

b Pharmaceutical Safety Assessments Inc (United States)

c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE (United States)

d Pharmacia (United States)

e UNIVERSITY OF CONNECTICUT HEALTH CENTER (United States)

f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; DRUG SCREENING; EMBOLISM PREVENTION; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; STATISTICAL ANALYSIS; STROKE; THROMBOEMBOLISM;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARDIOVASCULAR SYSTEM; CORONARY THROMBOSIS; CYCLOOXYGENASE INHIBITORS; DICLOFENAC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IBUPROFEN; MALE; PYRAZOLES; SULFONAMIDES;

EID: 0037083074 PISSN: 00029149 EISSN: None Source Type: Journal
DOI: 10.1016/S0002-9149(01)02265-2 Document Type: Article

Times cited : (217)

References (21)

1
- 0034041077
- Basic biology and clinical application of specific cyclooxygenase-2 inhibitors
- (2000) Arthritis Rheum , vol.43 , pp. 4-13
- Crofford, L.J.¹ Lipsky, P.E.² Brooks, P.³ Abramson, S.B.⁴ Simon, L.S.⁵ Van de Putte, L.B.A.⁶

2
- 0033601089
- Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis - A randomized controlled trial
- (1999) JAMA , vol.282 , pp. 1921-1928
- Simon, L.S.¹ Weaver, A.L.² Graham, D.Y.³ Kivitz, A.J.⁴ Lipsky, P.E.⁵ Hubbard, R.C.⁶

3
- 0033524421
- Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
- published erratum appears in Proc Natl Acad Sci USA 1999;96:5890
- (1999) Proc Natl Acad Sci USA , vol.96 , pp. 272-277
- McAdam, B.F.¹ Catella, L.F.² Mardini, I.A.³ Kapoor, S.⁴ Lawson, J.A.⁵ FitzGerald, G.A.⁶

4
- 0032948948
- Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids
- (1999) J Pharmacol Exp Ther , vol.289 , pp. 735-741
- Catella, L.F.¹ McAdam, B.² Morrison, B.W.³ Kapoor, S.⁴ Kujubu, D.⁵ Antes, L.⁶ Lasseter, K.C.⁷ Quan, H.⁸ Gertz, B.J.⁹ Fitzgerald, G.A.¹⁰

5
- 0034707105
- Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
- (2000) N Engl J Med , vol.343 , pp. 1520-1528
- Bombardier, C.¹ Laine, L.² Reicin, A.³ Shapiro, D.⁴ Burgos-Vargas, R.⁵ Davis, B.⁶ Day, R.⁷ Ferraz, M.B.⁸ Hawky, C.J.⁹ Hochberg, M.C.¹⁰ Kvien, T.K.¹¹ Schnitzer, T.J.¹²

6
- 0035934070
- Risk of cardiovascular events associated with selective COX-2 inhibitors
- (2001) JAMA , vol.286 , pp. 954-959
- Mukherjee, D.¹ Nissen, S.E.² Topol, E.J.³

7
- 0035925909
- NSAIDs and selective COX-2 inhibitors: Competition between gastroprotection and cardioprotection
- (2001) Lancet , vol.357 , pp. 1222-1223
- Boers, M.¹

8
- 0034644396
- Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial
- (2000) JAMA , vol.284 , pp. 1247-1255
- Silverstein, F.E.¹ Faich, G.² Goldstein, J.L.³ Simon, L.S.⁴ Pincus, T.⁵ Whelton, A.⁶ Makuch, R.⁷ Eisen, G.⁸ Agrawal, N.M.⁹

9
- 0008269249
- Division of Cardio-Renal Drug Products sultation on NDA 21-042 S-007
- Targum, S.¹

10
- 0030773146
- Aspirin as a therapeutic agent in cardiovascular disease: A statement for healthcare professionals from the American Heart Association
- (1997) Circulation , vol.96 , pp. 2751-2753
- Hennekens, C.H.¹ Dyken, M.L.² Fuster, V.³

11
- 0024477239
- Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol)
- (1989) Prostaglandins , vol.37 , pp. 311-315
- Green, K.¹ Drvota, V.² Vesterqvist, O.³

12
- 0032871514
- Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy
- (1999) Expert Opin Invest Drugs , vol.8 , pp. 1623-1638
- Koki, A.T.¹ Leahy, K.M.²

13
- 0032513878
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
- HOT Study Group
- (1998) Lancet , vol.351 , pp. 1755-1762
- Hansson, L.¹ Zanchetti, A.² Carruthers, S.G.³ Dahlof, B.⁴ Elmfeldt, D.⁵ Julius, S.⁶ Menard, J.⁷ Rahn, K.H.⁸ Wedel, H.⁹ Westerling, S.¹⁰

14
- 0032562005
- Thrombosis Prevention trial: Randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk
- The Medical Research Council's General Practice Research Framework
- (1998) Lancet , vol.351 , pp. 233-241

15
- 0034645456
- An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular disease
- (2000) Arch Intern Med , vol.160 , pp. 3123-3127
- Hebert, P.R.¹ Hennekens, C.H.²

16
- 0027250074
- Evaluation of flurbiprofen for prevention of reinfarction and reocclusion after successful thrombolysis or angioplasty in acute myocardial infarction: The Flurbiprofen French trial
- (1993) Eur Heart J , vol.14 , pp. 951-957
- Brochier, M.L.¹

17
- 0027473471
- Indobufen in the prevention of thromboembolic complications in patients with heart disease. A randomized, placebo-controlled, double-blind study
- (1993) Circulation , vol.87 , pp. 162-164
- Fornaro, G.¹ Rossi, P.² Mantica, P.G.³ Caccia, M.E.⁴ Aralda, D.⁵ Lavezzari, M.⁶ Pamparana, F.⁷ Milanesi, G.⁸

18
- 0031866645
- Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery: Results of a combined analysis
- (1998) Coron Artery Dis , vol.9 , pp. 217-222
- Cataldo, G.¹ Heiman, F.² Lavezzari, M.³ Marubini, E.⁴

19
- 0023137593
- Inhibition of thromboxane formation in vivo and ex vivo: Implications for therapy with platelet inhibitory drugs
- (1987) Blood , vol.69 , pp. 180-186
- Reilly, I.A.¹ FitzGerald, G.A.²

20
- 0033933177
- Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women
- (2000) Epidemiology , vol.11 , pp. 382-387
- Rodriguez, L.A.G.¹ Varas, C.² Patrono, C.³

21
- 0035286901
- Cyclooxygenase-2-specific inhibitors and cardiorenal function: A randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients
- (2001) Am J Ther , vol.8 , pp. 85-96
- Whelton, A.¹ Fort, J.G.² Puma, J.A.³ Normandin, D.⁴ Bello, A.E.⁵ Verburg, K.M.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.